Pooling and expanding registries of familial hypercholesterolaemia toassess gaps in care and improve disease management and outcomes:Rationale and design of the global EAS Familial HypercholesterolaemiaStudies Collaboration
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
